Dynamics of global disclosure through patent and journal publications for biopharmaceutical products.

Nat Biotechnol

Molecular Immunology Unit, Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, Cranmer Terrace, London, UK.

Published: July 2009

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt0709-614DOI Listing

Publication Analysis

Top Keywords

dynamics global
4
global disclosure
4
disclosure patent
4
patent journal
4
journal publications
4
publications biopharmaceutical
4
biopharmaceutical products
4
dynamics
1
disclosure
1
patent
1

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Alzheimer's disease pathophysiology is believed to involve various abnormalities, including those of amyloid beta (Ab) peptide and tau processing, inflammation, oxidative stress, and vascular risk factors. Aβ peptides exist in a dynamic continuum of conformational states from monomeric Aβ, to soluble progressively larger Aβ assemblies that include a range of low molecular weight oligomers to higher molecular weight protofibrils, and finally to insoluble fibrils (plaques). Various lines of evidence support the "amyloid hypothesis" that Aβ plays a central role in the pathogenesis of AD, and several immunotherapies have been developed to interact with this cascade in various different places which may reduce the number of soluble aggregates and insoluble Aβ fibrils deposited in the brain.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Eisai Inc., Nutley, NJ, USA.

Background: Lecanemab is an approved anti-amyloid monoclonal antibody that binds with highest affinity to soluble Aβ protofibrils, which are more toxic than monomers or insoluble fibrils/plaque. In clinical studies, biweekly lecanemab treatment demonstrated a slowing of decline in clinical (global, cognitive, functional, and quality of life) outcomes, and reduction in brain amyloid in early Alzheimer's disease (AD). Herein, we describe the impact of lecanemab treatment on tau PET.

View Article and Find Full Text PDF

Background: Dementia, including its younger-onset variant, increasingly challenges diverse workplaces, affecting both employees living with dementia and their employers. With a growing global trend of individuals extending their working years, it becomes crucial to understand the specific challenges and implications for those with dementia within various employment contexts. This review delves into the cognitive, interpersonal, and organizational challenges faced by employees living with dementia across a broad range of workplaces, reflecting the evolving dynamics of today's work environment.

View Article and Find Full Text PDF

Background: This ethnographic inquiry offers a nuanced exploration into the lives of individuals contending with dementia in India, utilizing data from the Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India (LASI-DAD). Recognizing dementia as a complex global health challenge, we delve into its unique manifestations within India's diverse regional and cultural landscape. While LASI-DAD provides valuable quantitative insights into prevalence and risk factors, our research complements these statistics by providing an in-depth understanding of the daily lives and lifestyles of those affected.

View Article and Find Full Text PDF

Reorganization of Dynamic Network in Stroke Patients and Its Potential for Predicting Motor Recovery.

Neural Plast

January 2025

Department of Neurology, The Fifth Affiliated hospital of Guangxi Medical University, The First People's Hospital of Nanning, Nanning, China.

The investigation of brain functional network dynamics offers a promising approach to understanding network reorganization poststroke. This study aims to explore the dynamic network configurations associated with motor recovery in stroke patients and assess their predictive potential using multilayer network analysis. Resting-state functional magnetic resonance imaging data were collected from patients with subacute stroke within 2 weeks of onset and from matched healthy controls (HCs).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!